CORDIS
EU research results

CORDIS

English EN

Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics

Project information

Grant agreement ID: 734907

Status

Ongoing project

  • Start date

    1 January 2017

  • End date

    31 December 2020

Funded under:

H2020-EU.1.3.3.

  • Overall budget:

    € 945 000

  • EU contribution

    € 945 000

Coordinated by:

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Ireland

Objective

Severe ocular disorders are affecting the lives of more than 100Mill people world-wide and at least 25% of the population above 70 years of age, a growing demographic group in EU. More than 8 million people lose their lives to cancer every year, making cancer a leading cause of pre-mature mortality in the world. The main hallmarks of severe eye conditions (i.e angiogenesis, inflammation and vascular permeability) play also pivotal roles in cancer, being therapeutic targets to treat both kind of diseases.

The overall goal of 3D-NEONET is the improvement of available treatments for cancer and ocular disease by enhancing drug discovery-development and delivery to targeted tissues, through advanced international co-operation between academic and non-academic partners. The interdisciplinary expertise provided by 18 partners in 7 countries encompasses among others: drug screens, ADME, toxicology, preclinical models, nanotechnology, biomaterials and clinical trials.

After the success with ongoing FP7-IAPP project 3D-NET (Drug Discovery and Development of Novel Eye Therapeutics; (www.ucd.ie/3dnet), we are assembling 3D-NEONET, this enlarged European interdisciplinary consortium that will join forces and exchange skills to enhance current therapies in oncology and ophthalmology.
The 3 global objectives of 3D-NEONET are:
1- Enhance the discovery and development of novel drugs, targets and biomarkers for ophthalmology and oncology.
2- Improve the Delivery of Therapeutics for Oncology and Ophthalmology
3- Enhancement of Research, Commercial and Clinical Trial Project Management Practices in these fields.

Through participation in the program, 3D-NEONET is the vehicle for driving synergies between academic and non-academic partners leading to increased scientific and technological excellence as well as tangible innovative outputs that will strengthen the competitiveness of both the researchers and industries of the network even beyond the lifetime of the network.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Address

Belfield
4 Dublin

Ireland

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 204 975

Participants (20)

UNIVERSIDAD DE VALLADOLID

Spain

EU Contribution

€ 9 000

LINKOPINGS UNIVERSITET

Sweden

EU Contribution

€ 18 000

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN

Ireland

EU Contribution

€ 31 500

LABORATORIO IBERICO INTERNACIONAL DE NANOTECNOLOGIA

Portugal

EU Contribution

€ 51 750

NATIONAL UNIVERSITY OF IRELAND GALWAY

Ireland

EU Contribution

€ 27 000

THE QUEEN'S UNIVERSITY OF BELFAST

United Kingdom

EU Contribution

€ 70 470

UNIVERSIDAD COMPLUTENSE DE MADRID

Spain

EU Contribution

€ 90 000

KARLSRUHER INSTITUT FUER TECHNOLOGIE

Germany

EU Contribution

€ 9 450

ZECLINICS SL

Spain

EU Contribution

€ 9 000

HGBEYOND MATERIALS SICENCE SL

Spain

EU Contribution

€ 18 000

EXPERIMENTELLE PHARMAKOLOGIE UND ONKOLOGIE BERLIN-BUCH GMBH

Germany

XENOPAT SL

Spain

EU Contribution

€ 18 000

ECM INGENIERIA AMBIENTAL SL

Spain

EU Contribution

€ 74 250

ICON CLINICAL RESEARCH LIMITED

Ireland

OCUPHARM DIAGNOSTICS SL

Spain

EU Contribution

€ 259 605

ASHLAND SPECIALTIES IRELAND LIMITED

Ireland

BLAFAR LIMITED

Ireland

EU Contribution

€ 40 500

WATERFORD INSTITUTE OF TECHNOLOGY

Ireland

EU Contribution

€ 9 000

BIOREPERIA AB

Sweden

EU Contribution

€ 4 500

CRESSET BIOMOLECULAR DISCOVERY LIMITED

United Kingdom

Partners (1)

EYECRO LLC

United States

Project information

Grant agreement ID: 734907

Status

Ongoing project

  • Start date

    1 January 2017

  • End date

    31 December 2020

Funded under:

H2020-EU.1.3.3.

  • Overall budget:

    € 945 000

  • EU contribution

    € 945 000

Coordinated by:

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Ireland